Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8G9W | Q2N0S6 | Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1) | |
| 8G9W | 8G9W | Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1) | |
| 8G8W | P25874 | Molecular mechanism of nucleotide inhibition of human uncoupling protein 1 | |
| 8G8W | P0AEX9 | Molecular mechanism of nucleotide inhibition of human uncoupling protein 1 | |
| 8G8W | 8G8W | Molecular mechanism of nucleotide inhibition of human uncoupling protein 1 | |
| 8G8W | P0AEX9 | Molecular mechanism of nucleotide inhibition of human uncoupling protein 1 | |
| 8G8W | 8G8W | Molecular mechanism of nucleotide inhibition of human uncoupling protein 1 | |
| 8G8C | 8G8C | Crystal structure of DH1322.1 Fab in complex with HIV proximal MPER peptide | |
| 8G8C | A4UIY1 | Crystal structure of DH1322.1 Fab in complex with HIV proximal MPER peptide | |
| 8G8A | 8G8A | Crystal structure of DH1317.8 Fab in complex with HIV proximal MPER peptide | |
| 8G8A | Q69910 | Crystal structure of DH1317.8 Fab in complex with HIV proximal MPER peptide | |
| 8G85 | 8G85 | vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer | |
| 8G85 | Q2N0S6 | vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer | |
| 8G82 | 8G82 | Vancomycin bound to D-Ala-D-Ser | |
| 8G7C | P0DTC2 | local refinement of SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
| 8G7C | 8G7C | local refinement of SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
| 8G7B | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 (local refinement) | |
| 8G7B | 8G7B | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 (local refinement) | |
| 8G7A | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 (local refinement) | |
| 8G7A | 8G7A | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 (local refinement) | |
| 8G78 | P0DTC2 | Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD | |
| 8G78 | 8G78 | Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD | |
| 8G77 | P0DTC2 | SARS-CoV-2 spike/Nb6 complex | |
| 8G77 | 8G77 | SARS-CoV-2 spike/Nb6 complex | |
| 8G76 | P0DTC2 | SARS-CoV-2 spike/Nb5 complex | |
| 8G76 | 8G76 | SARS-CoV-2 spike/Nb5 complex | |
| 8G75 | P0DTC2 | SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
| 8G75 | 8G75 | SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
| 8G74 | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 | |
| 8G74 | 8G74 | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 | |
| 8G73 | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A | |
| 8G73 | 8G73 | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A | |
| 8G71 | P0DTC2 | Spike/Nb2 complex with 1 RBD up | |
| 8G70 | P0DTC2 | SARS-CoV-2 spike/nanobody mixture complex | |
| 8G70 | 8G70 | SARS-CoV-2 spike/nanobody mixture complex | |
| 8G6U | A0A6C0ZY47 | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with 8ANC195 and 10-1074 | |
| 8G6U | 8G6U | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with 8ANC195 and 10-1074 | |
| 8G6I | P00451 | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
| 8G6I | P12263 | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
| 8G6I | 8G6I | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
| 8G5X | A0A0E2ZJY0 | Structure of the Class II Fructose-1,6-Bisphophatase from Francisella tularensis complexed with native metal cofactor Mn++ and substrate Fructose-1,6-Bisphosphate | |
| 8G5H | P26049 | Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5H | P63137 | Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5H | P62812 | Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5H | P22723 | Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5H | 8G5H | Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5G | P62812 | Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5G | P63137 | Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5G | P26049 | Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5G | P22723 | Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid |
